Medicare Enrolled
Dr. Thomas Spillane, MD
Medical Oncology · San Luis Obispo, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Spillane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spillane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Spillane
Dr. Thomas Spillane is a medical oncology specialist in San Luis Obispo, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Spillane performed 2,671 Medicare services across 1,350 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spillane received a total of $54,230 from 98 pharmaceutical and/or device companies across 1705 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spillane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 23% volume in CA
$54,230 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,671
Medicare services
Top 23% in CA for medical oncology
1,350
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~134 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,743 | $100 | $284 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
525 | $72 | $196 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
205 | $143 | $310 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $127 | $430 |
| New patient office visit, complex (60-74 min) | 49 | $173 | $436 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $87 | $282 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $41 | $118 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
17 | $107 | $236 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $70 | $163 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$54,230
Total received (2018-2024)
Avg $7,747/year across 7 years
Top 18% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
98
Companies
1,705
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,881 (53.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$23,399 (43.1%)
Other
Charitable contributions, space rental, and other categories
$1,398 (2.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$552 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,697
2023
$4,914
2022
$11,368
2021
$14,151
2020
$9,656
2019
$4,268
2018
$2,177
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer Healthcare Pharmaceuticals Inc.
$1,247
AstraZeneca Pharmaceuticals LP
$854
Janssen Biotech, Inc.
$476
ABBVIE INC.
$374
Daiichi Sankyo Inc.
$348
Exelixis Inc.
$348
PFIZER INC.
$302
Astellas Pharma US Inc
$292
Merck Sharp & Dohme LLC
$281
Genentech USA, Inc.
$276
SOBI, INC
$255
Novartis Pharmaceuticals Corporation
$231
Celgene Corporation
$183
Alnylam Pharmaceuticals Inc.
$172
PharmaEssentia USA Corporation
$159
Blueprint Medicines Corporation
$159
Genmab U.S., Inc.
$148
GlaxoSmithKline, LLC.
$139
E.R. Squibb & Sons, L.L.C.
$138
Lilly USA, LLC
$122
ADC Therapeutics America, Inc.
$98
Eisai Inc.
$90
Takeda Pharmaceuticals U.S.A., Inc.
$76
GENZYME CORPORATION
$75
Mirati Therapeutics, Inc.
$66
Apellis Pharmaceuticals, Inc.
$65
Alexion Pharmaceuticals, Inc.
$62
Gilead Sciences, Inc.
$54
ARRAY BIOPHARMA INC
$51
PUMA BIOTECHNOLOGY, INC.
$50
Deciphera Pharmaceuticals Inc.
$43
RECORDATI_RARE_DISEASES_INC.
$39
Karyopharm Therapeutics Inc.
$32
Stemline Therapeutics Inc.
$31
Incyte Corporation
$31
Medtronic, Inc.
$29
Pharmacosmos Therapeutics Inc.
$29
TAIHO ONCOLOGY, INC.
$27
Ipsen Biopharmaceuticals, Inc
$24
Coherus Biosciences Inc.
$23
SERVIER PHARMACEUTICALS LLC
$22
JAZZ PHARMACEUTICALS INC.
$22
EMD Serono, Inc.
$22
SpringWorks Therapeutics, Inc.
$22
Fresenius Kabi USA, LLC
$21
BeiGene USA, Inc.
$21
Rigel Pharmaceuticals, Inc.
$20
Aveo Pharmaceuticals, Inc.
$19
MorphoSys, US Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Top 3 companies account for 33.5% of 2024 payments
All-time payments by company (2018-2024) ›
Bayer HealthCare Pharmaceuticals Inc.
$11,898
AstraZeneca Pharmaceuticals LP
$7,249
Novartis Pharmaceuticals Corporation
$2,649
E.R. Squibb & Sons, L.L.C.
$2,056
Janssen Scientific Affairs, LLC
$1,743
Karyopharm Therapeutics Inc.
$1,689
Janssen Biotech, Inc.
$1,624
Bayer Healthcare Pharmaceuticals Inc.
$1,384
Genentech USA, Inc.
$1,361
Amgen Inc.
$1,357
Daiichi Sankyo Inc.
$1,323
Astellas Pharma US Inc
$1,219
Seagen Inc.
$1,115
Exelixis Inc.
$1,069
Merck Sharp & Dohme Corporation
$860
Celgene Corporation
$788
PFIZER INC.
$778
GlaxoSmithKline, LLC.
$758
Blueprint Medicines Corporation
$666
Takeda Pharmaceuticals U.S.A., Inc.
$665
GENZYME CORPORATION
$658
EMD Serono, Inc.
$647
Merck Sharp & Dohme LLC
$601
Pharmacyclics LLC, An AbbVie Company
$527
BeiGene, Ltd.
$525
Eisai Inc.
$486
Lilly USA, LLC
$459
Incyte Corporation
$438
ABBVIE INC.
$404
Alexion Pharmaceuticals, Inc.
$378
Rigel Pharmaceuticals, Inc.
$367
Clovis Oncology, Inc.
$316
SOBI, INC
$304
Puma Biotechnology, Inc.
$285
ADC Therapeutics America, Inc.
$278
PharmaEssentia USA Corporation
$237
Dendreon Pharmaceuticals LLC
$229
EISAI INC.
$226
Kite Pharma, Inc.
$207
AMAG Pharmaceuticals, Inc.
$201
JAZZ PHARMACEUTICALS INC.
$185
BeiGene USA, Inc.
$184
Alnylam Pharmaceuticals Inc.
$172
MorphoSys, US Inc.
$170
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Stemline Therapeutics Inc.
$163
Regeneron Healthcare Solutions, Inc.
$161
Genmab U.S., Inc.
$148
ARRAY BIOPHARMA INC
$145
AbbVie, Inc.
$130
Boehringer Ingelheim Pharmaceuticals, Inc.
$129
Seattle Genetics, Inc.
$128
Mirati Therapeutics, Inc.
$120
Array BioPharma Inc.
$120
Ipsen Biopharmaceuticals, Inc
$115
PUMA BIOTECHNOLOGY, INC.
$110
SANOFI-AVENTIS U.S. LLC
$104
AVEO Pharmaceuticals, Inc.
$102
Myovant Sciences Inc.
$102
Apellis Pharmaceuticals, Inc.
$98
AbbVie Inc.
$89
Sobi, Inc
$88
Gilead Sciences, Inc.
$88
Pharmacyclics LLC, an AbbVie Company
$85
Secura Bio, Inc.
$80
TOLMAR Pharmaceuticals, Inc.
$78
Dova Pharmaceuticals
$65
TAIHO ONCOLOGY, INC.
$53
TerSera Therapeutics LLC
$49
Coherus Biosciences Inc.
$48
Epizyme, Inc.,
$46
Deciphera Pharmaceuticals Inc.
$43
Kyowa Kirin, Inc.
$43
Myriad Genetic Laboratories, Inc.
$41
TESARO, Inc.
$39
RECORDATI_RARE_DISEASES_INC.
$39
SECURA BIO, INC.
$35
ImmunoGen, Inc.
$32
Acrotech Biopharma LLC
$30
Agios Pharmaceuticals, Inc.
$30
Medtronic, Inc.
$29
Pharmacosmos Therapeutics Inc.
$29
Heron Therapeutics, Inc.
$27
Helsinn Therapeutics (U.S.), Inc.
$26
SERVIER PHARMACEUTICALS LLC
$22
SpringWorks Therapeutics, Inc.
$22
Fresenius Kabi USA, LLC
$21
Aveo Pharmaceuticals, Inc.
$19
Sirtex Medical Inc
$19
CTI BioPharma Corp.
$19
Mylan Institutional Inc.
$18
Verastem, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$16
Nestle HealthCare Nutrition Inc.
$15
Foundation Medicine, Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Organon LLC
$14
Sun Pharmaceutical Industries Inc.
$13
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · Alecensa · Aranesp · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYNFEZIA PEN · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COPIKTRA · CREON · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FARYDAK · FASLODEX · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fulphila · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · Itovebi · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · PreciseTumor · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNCHROMEDII · Stimufend · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tepmetko · Tibsovo · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vanflyta · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZENPEP · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
1
Per 100K population
0.4
County median income
$93,398
Nearest hospital
FRENCH HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Spillane is a clinical cardiology specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement in the top 18% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Spillane experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Spillane performed 1,743 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spillane receive payments from pharmaceutical companies?
Yes. Dr. Spillane received a total of $54,230 from 98 companies across 1,705 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spillane's costs compare to other medical oncologists in San Luis Obispo?
Dr. Spillane's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spillane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in San Luis Obispo
Browse medical oncologists in San Luis Obispo ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in CA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in CA
Which CA medical oncologists receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology